Brief: Neurocrine Biosciences Announces Publication On Traditional Glucocorticoid Treatment In Classic Congenital Adrenal Hyperplasia
08/01/2025 14:26
Jan 8 (Reuters) - Neurocrine Biosciences Inc NBIX.O :
* NEUROCRINE BIOSCIENCES ANNOUNCES PUBLICATION ON
TRADITIONAL
GLUCOCORTICOID TREATMENT IN CLASSIC CONGENITAL ADRENAL
HYPERPLASIA IN EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM
Source text: urn:newsml:reuters.com:*:nPncc4sm3a
Further company coverage: NBIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurocrine Biosciences
See all newsBrief: Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating Nbi-'567 In Adults With Alzheimer's Disease
Nxera Pharma's Partner Neurocrine Biosciences Receives Ind Acceptance From FDA For Phase 2 Study Of Nbi-1117567 For Alzheimer's Cognition
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Prader-Willi groups cite deaths tied to Neurocrine's genetic disorder drug, shares fall